These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14621733)

  • 1. Verapamil (VP) improves the outcome after renal transplantation (CRT).
    Dawidson I; Lu C; Palmer B; Peters P; Rooth P; Risser R; Sagalowsky A; Sandor Z
    Transpl Int; 1992; 5 Suppl 1():S60-2. PubMed ID: 14621733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcium channel blockers in renal allograft patients receiving cyclosporine.
    Suh BY; Kwun OS; Kwun KB
    Transplant Proc; 1998 Nov; 30(7):3558-60. PubMed ID: 9838558
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.
    Gossmann J; Mondorf U; Dietz A; Kramer W; Kachel HG; Geiger H; Scheuermann EH
    Transplant Proc; 2002 Aug; 34(5):1767-70. PubMed ID: 12176568
    [No Abstract]   [Full Text] [Related]  

  • 4. Verapamil improves the outcome after cadaver renal transplantation.
    Dawidson I; Rooth P; Lu C; Sagalowsky A; Diller K; Palmer B; Peters P; Risser R; Sandor Z; Seney F
    J Am Soc Nephrol; 1991 Nov; 2(5):983-90. PubMed ID: 1760541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative fluid and drug therapy during cadaver kidney transplantation.
    Dawidson IJ; Ar'Rajab A
    Clin Transpl; 1992; ():267-84. PubMed ID: 1306705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion of renal allografts with verapamil improves graft function.
    Nguan CY; Sener A; Karnik V; Caumartin Y; House AA; McAlister VC; Luke PP
    Transplantation; 2008 Nov; 86(10):1463-7. PubMed ID: 19034018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
    Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
    Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil.
    Dawidson I; Rooth P; Fry WR; Sandor Z; Willms C; Coorpender L; Alway C; Reisch J
    Transplantation; 1989 Oct; 48(4):575-80. PubMed ID: 2678635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients.
    Harper SJ; Moorhouse J; Veitch PS; Horsburgh T; Walls J; Bell PR; Donnelly PK; Feehally J
    Transpl Int; 1992; 5 Suppl 1():S69-72. PubMed ID: 14621737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
    Kasiske BL; Johnson HJ; Goerdt PJ; Heim-Duthoy KL; Rao VK; Dahl DC; Ney AL; Andersen RC; Jacobs DM; Odland MD
    Am J Kidney Dis; 1997 Nov; 30(5):639-45. PubMed ID: 9370178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
    Castelao AM; Griño JM; Sabate I; Seron D; Andres E; Gilvernet S; Bover J; Gonzalez C; Alsina J
    Transpl Int; 1992; 5 Suppl 1():S58-9. PubMed ID: 14621732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
    Thomas DW; Baboolal K; Subramanian N; Newcombe RG
    J Clin Periodontol; 2001 Jul; 28(7):706-9. PubMed ID: 11422595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft loss.
    Bianco PD; Silva HT; Boni R; Machado PG; Pacheco-Silva A; Pestana JO
    Transplant Proc; 2002 Nov; 34(7):2920-1. PubMed ID: 12431657
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine.
    Cransberg K; Bouts AH; Cornelissen EA; Lilien MR; Van Hoeck KJ; Hop WC; Nauta J
    Transplantation; 2008 Nov; 86(9):1199-205. PubMed ID: 19005400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of rejection rates and kidney graft survival: a historical analysis.
    Marcén R; Fernández-Rodriguez A; Rodríguez-Mendiola N; Ponte B; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2357-9. PubMed ID: 19715918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.